从109 695个基于实体瘤组织的综合基因组资料中获得临床意义的见解
Andreas M Heilmann1, Jonathan W Riess2, Margaret McLaughlin-Drubin1
1Foundation Medicine, Cambridge, MA, USA.
The oncologist
|September 8, 2023
概括
基金会OneCDx瘤分析在约一半患有固体瘤的患者中发现了临床显著的基因组变化. 这些发现为癌症治疗决策和临床试验资格提供了宝贵的见解.
科学领域:
- 基因组医学是一种基因组医学.
- 在瘤学瘤学.
- 分子诊断学 分子诊断学
背景情况:
- FoundationOneCDx是美国和日本批准的伴随诊断测试.
- 它确定了有资格接受30种 (美国) 和23种 (日本) 药物治疗的患者.
- 除了伴随诊断之外,它还检测出临床上重要的基因组发现,用于更广泛的护理决策.
研究的目的:
- 报告从 FoundationOneCDx 实体瘤档案中获得的临床决策见解的广度和影响.
- 分析综合基因组分析在常规临床护理中的实用性.
主要方法:
- 对109,695个连续的FoundationOneCDx固体瘤测试报告进行了回顾性分析.
- 鉴定临床显著的预测性,预后性和诊断性基因组变化和签名.
- 根据可采取行动,调查或假设的目标,将瘤形状与干预性临床试验相匹配.
主要成果:
- 临床显著的预测,预后和诊断标记在51.2%的所有瘤形状中被报告.
- 观察到泛癌预测标志物,如高瘤突变负担 (TMB) 和微卫星不稳定性 (MSI).
- 89.2%的个人资料具有基因组结果,可能为免疫疗法和向治疗临床试验选择提供信息.
结论:
- 大约有一半具有固体瘤形状的患者显示出临床显著的基因组发现.
- 基金会OneCDx为现实世界癌症患者护理提供了有价值的基因组见解.
- 这些发现支持在常规瘤实践中使用全面的基因组分析.
相关概念视频
Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


